ICPT
ICPT Articles
We screened our 24/7 Wall St. research database for hot biotech ideas and found four companies that are offering big upside for aggressive accounts. All are rated Buy and have the potential to...
Published:
Last Updated:
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Published:
Last Updated:
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Published:
Last Updated:
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Published:
Last Updated:
These four momentum biotech plays still have solid upside to the Jefferies price targets and would be solid additions to aggressive accounts with higher risk tolerance.
Published:
Last Updated:
Windstream, Uniti Group, Intercept Pharmaceuticals, and Genocea Biosciences all posted new 52-week lows on Wednesday.
Published:
Last Updated:
Versartis, Intercept Pharma, Kroger, and Mattel all posted new 52-week lows on Friday.
Published:
Last Updated:
Kroger, Bed Bath & Beyond, Intercept Pharmaceuticals, and Mattel all posted new 52-week lows on Thursday.
Published:
Last Updated:
As we have said before, updates from the FDA have the potential to make or break a company. In this case it seems like a mild setback, but further complications could prove to be catastrophic.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson, 3M, Intercept Pharmaceutical and AutoZone.
Published:
Last Updated:
HP Enterprise, Discovery Communications, Intercept Technologies, and Advaxis all posted new 52-week lows on Tuesday.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Published:
Last Updated:
Friday’s top analyst upgrades, downgrades and initiations include Apache, Baker Hughes, Jack in the Box, Rite Aid, Synchrony Financial and U.S. Steel.
Published:
Last Updated:
Friday's top analyst calls include Alibaba, Amazon, Bank of America, Cypress Semiconductor, Flextronics, JC Penney, Lululemon Athletica and Microsoft.
Published:
Last Updated:
Intercept Pharmaceuticals announced that the FDA has extended the PDUFA date for its Priority Review of obeticholic acid in primary biliary cholangitis.
Published:
Last Updated: